2025
|
Invention
|
Synthesis of small molecule agonists of neuroptrophin.
The disclosure concerns a process for syn... |
|
Invention
|
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliv... |
2024
|
Invention
|
Method of treating diabetic macular edema. The present disclosure relates to a method of treating... |
|
Invention
|
Method of treating diabetic macular edema.
The present disclosure relates to a method of treatin... |
|
Invention
|
Treatment of ocular inflammation following ocular surgery. The present disclosure relates to a me... |
|
Invention
|
Treatment of ocular inflammation with ophthalmic compositions. The present disclosure relates to ... |
|
Invention
|
Ph stabilized ophthalmic dexamethasone compositions. The present disclosure relates to a method f... |
|
Invention
|
Ph stabilized ophthalmic compositions. The present disclosure relates to a method for stabilizing... |
|
Invention
|
Stabilized ophthalmic dexamethasone compositions. The present disclosure relates to a method for ... |
|
Invention
|
Treatment of diabetic retinopathy with ophthalmic compositions. The present disclosure relates to... |
|
Invention
|
Multidose ophthalmic compositions.
The present invention relates to aqueous cyclodextrin composi... |
2023
|
Invention
|
Synthesis of small molecule agonists of neuroptrophin. 11616161233 is chosen from propyl, 1-methy... |
|
Invention
|
Ph stabilized topical ophthlamic compositions.
The present disclosure relates to a method for st... |
|
Invention
|
Treatment of ocular inflammation. The present disclosure relates to a method for stabilizing the ... |
|
Invention
|
Ocular inflammation treatment with stabilized dexamethasone.
The present disclosure relates to a... |
|
Invention
|
Treatment of diabetic retinopathy. The present disclosure relates to a method for stabilizing the... |
|
Invention
|
Stabilized dexamethasone compositions. The present disclosure relates to a method for stabilizing... |
|
Invention
|
Eye drop microsuspensions of mtor inhibitors. The present invention relates to an aqueous eye dro... |
2021
|
P/S
|
Substances et préparations médicales et pharmaceutiques, nommément préparations pharmaceutiques p... |
|
P/S
|
Medical and pharmaceutical preparations and substances;
liquid solutions for the treatment of op... |
|
P/S
|
Pharmaceutical preparations of solid cyclodextrin complexes for topical ophthalmic drug delivery |
|
P/S
|
Pharmaceutical preparations of solid cyclodextrin complexes
for topical ophthalmic drug delivery. |
|
P/S
|
Topical drug formulation for ophthalmic use |
|
P/S
|
Topical drug formulation for ophthalmic use. |
2020
|
Invention
|
Diabetic retinopathy treatment with stabilized dexamethasone. A method is described of stabilizin... |
2019
|
P/S
|
Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical prep... |